medigraphic.com
ISSN 2992-8036 (Digital)
ISSN 2306-4102 (Impreso)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2013, Número S1

<< Anterior Siguiente >>

Acta Ortop Mex 2013; 27 (S1)


Conservación sanguínea

Idioma: Español
Referencias bibliográficas: 95
Paginas: 82-90
Archivo PDF: 194.45 Kb.


FRAGMENTO

Pregunta 1: ¿La transfusión sanguínea se asocia a un incremento en la tasa de infección del sitio quirúrgico (ISQx) y de la infección articular periprotésica (IAP)?


Consenso: Sí. Las transfusiones alogénicas están asociadas con un incremento en el riesgo de ISQx/IAP. El papel de la transfusión autóloga en el riesgo de ISQx/IAP no es concluyente.
Voto de los delegados: De acuerdo, 91%; en desacuerdo, 5%; abstenciones, 4%. (Consenso fuerte.)


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Healthcare Infection Control Practice Advisory Committee. CDC and HICPAC Draft Guideline for Prevention of Surgical Site Infection, Arthroplasty Section [Internet]. Pending.

  2. Innerhofer P, Klingler A, Klimmer C, Fries D, Nussbaumer W: Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion. 2005; 45(1): 103-110.

  3. Frietsch T, Karger R, Scholer M, et al: Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay. Transfusion. 2008; 48(10): 2133-2142.

  4. Carson JL, Terrin ML, Noveck H, et al: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011; 365(26): 2453-2462.

  5. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340(6): 409-417.

  6. Basora M, Pereira A, Soriano A, et al: Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty. Vox Sang. 2010; 98(2): 124-129.

  7. Brandt C, Hansen S, Sohr D, Daschner F, Ruden H, Gastmeier P: Finding a method for optimizing risk adjustment when comparing surgical-site infection rates. Infect Control Hosp Epidemiol. 2004; 25(4): 313-318.

  8. Byrne AM, Morris S, McCarthy T, Quinlan W, O’Byrne JM: Outcome following deep wound contamination in cemented arthroplasty. Int Orthop. 2007; 31(1): 27-31.

  9. Dale H, Hallan G, Espehaug B, Havelin LI, Engesaeter LB: Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop. 2009; 80(6): 639-645.

  10. Gastmeier P, Sohr D, Brandt C, Eckmanns T, Behnke M, Ruden H: Reduction of orthopaedic wound infections in 21 hospitals. Arch Orthop Trauma Surg. 2005; 125(8): 526-530.

  11. Jamsen E, Varonen M, Huhtala H, et al: Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty. 2010; 25(1): 87-92.

  12. Mraovic B, Suh D, Jacovides C, Parvizi J: Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol. 2011; 5(2): 412-418.

  13. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J: Prosthetic joint infection risk after total hip arthroplasty in the medicare population. J Arthroplasty. 2009; 24(6 Suppl): 105-109.

  14. Peersman G, Laskin R, Davis J, Peterson M: Infection in total knee replacement: a retrospective review of 6,489 total knee replacements. Clin Orthop Relat Res. 2001; (392): 15-23.

  15. Procter LD, Davenport DL, Bernard AC, Zwischenberger JB: General surgical operative duration is associated with increased risk-adjusted infectious complication rates and length of hospital stay. J Am Coll Surg. 2010; 210(1): 60-65 e61-62.

  16. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J: Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res. 2008; 466(7): 1710-1715.

  17. Willis-Owen CA, Konyves A, Martin DK: Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5,277 cases. J Bone Joint Surg Br. 2010; 92(8): 1128-1133.

  18. Park JH, Rasouli MR, Mortazavi SMJ, Tokarski AT, Maltenfort MG, Parvizi J: Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013; in Press.

  19. Faris PM, Spence RK, Larholt KM, Sampson AR, Frei D: The predictive power of baseline hemoglobin for transfusion risk in surgery patients. Orthopedics. 1999; 22(1 Suppl): s135-140.

  20. Perazzo P, Vigano M, De Girolamo L, et al: Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation. Blood Transfus. 2013; 11(7): 370-376.

  21. Hamaji A, Hajjar L, Caiero M, et al: Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection. Rev Bras Anestesiol. 2013; 63(1): 27-35.

  22. Xie R, Wang L, Bao H: Crystalloid and colloid preload for maintaining cardiac output in elderly patients undergoing total hip replacement under spinal anesthesia. J Biomed Res. 2013; 25(3): 185-190.

  23. Casutt M, Kristoffy A, Schuepfer G, Spahn DR, Konrad C: Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer’s solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Br J Anaesth. 2010; 105(3): 273-281.

  24. Guay J: The effect of neuraxial blocks on surgical blood loss and blood transfusion requirements: a meta-analysis. J Clin Anesth. 2006; 18(2): 124-128.

  25. Hu S, Zhang ZY, Hua YQ, Li J, Cai ZD: A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis. J Bone Joint Surg Br. 2009; 91(7): 935-942.

  26. Macfarlane AJ, Prasad GA, Chan VW, Brull R: Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review. Br J Anaesth. 2009; 103(3): 335-345.

  27. Macfarlane AJ, Prasad GA, Chan VW, Brull R: Does regional anesthesia improve outcome after total knee arthroplasty? Clin Orthop Relat Res. 2009; 467(9): 2379-2402.

  28. Mauermann WJ, Shilling AM, Zuo Z: A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis. Anesth Analg. 2006; 103(4): 1018-1025.

  29. Stundner O, Chiu YL, Sun X, et al: Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty. Reg Anesth Pain Med. 2012; 37(6): 638-644.

  30. Memtsoudis SG, Sun X, Chiu YL, et al: Perioperative comparative effectiveness of anesthetic technique in orthopedic patients. Anesthesiology. 2013; 118(5): 1046-1058.

  31. Paul JE, Ling E, Lalonde C, Thabane L: Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anaesth. 2007; 54(10): 799-810.

  32. Wedel DJ, Horlocker TT: Regional anesthesia in the febrile or infected patient. Reg Anesth Pain Med. 2006; 31(4): 324-333.

  33. Gritsenko K, Marcello D, Liguori GA, Jules-Elysee K, Memtsoudis SG: Meningitis or epidural abscesses after neuraxial block for removal of infected hip or knee prostheses. Br J Anaesth. 2012; 108(3): 485-490.

  34. Chang CC, Lin HC, Lin HW: Anesthetic management and surgical site infections in total hip or knee replacement: a population-based study. Anesthesiology. 2010; 113(2): 279-284.

  35. Barsoum WK, Klika AK, Murray TG, Higuera C, Lee HH, Krebs VE: Prospective randomized evaluation of the need for blood transfusion during primary total hip arthroplasty with use of a bipolar sealer. J Bone Joint Surg Am. 2011; 93(6): 513-518.

  36. Zeh A, Messer J, Davis J, Vasarhelyi A, Wohlrab D: The Aquamantys system –an alternative to reduce blood loss in primary total hip arthroplasty? J Arthroplasty. 2010; 25(7): 1072-1077.

  37. Clement RC, Kamath AF, Derman PB, Garino JP, Lee GC: Bipolar sealing in revision total hip arthroplasty for infection: efficacy and cost analysis. J Arthroplasty. 2012; 27(7): 1376-1381.

  38. Waters JH, Tuohy MJ, Hobson DF, Procop G: Bacterial reduction by cell salvage washing and leukocyte depletion filtration. Anesthesiology. 2003; 99(3): 652-655.

  39. Marulanda GA, Ulrich SD, Seyler TM, Delanois RE, Mont MA: Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008; 5(2): 125-131.

  40. Marulanda GA, Krebs VE, Bierbaum BE, et al: Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. Am J Orthop (Belle Mead NJ).2009; 38(12): E179-183.

  41. Parker MJ, Livingstone V, Clifton R, McKee A: Closed suction surgical wound drainage after orthopaedic surgery. Cochrane Database Syst Rev. 2007(3): CD001825.

  42. Parker MJ, Roberts CP, Hay D: Closed suction drainage for hip and knee arthroplasty. A meta-analysis. J Bone Joint Surg Am. 2004; 86-A(6): 1146-1152.

  43. Zamora-Navas P, Collado-Torres F, de la Torre-Solis F: Closed suction drainage after knee arthroplasty. A prospective study of the effectiveness of the operation and of bacterial contamination. Acta Orthop Belg. 1999; 65(1): 44-47.

  44. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM: Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br. 2011; 93(12): 1577-1585.

  45. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W: Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res. 2009; 123(5): 687-696.

  46. Roberts I, Perel P, Prieto-Merino D, et al: Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ. 2012; 345: e5839.

  47. Roberts I, Shakur H, Afolabi A, et al: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377(9771): 1096-1101, 1101 e1091-1092.

  48. Shakur H, Roberts I, Bautista R, et al: Effects of tranexamic acid on death, vascular occlusive events, and blood Transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734): 23-32.

  49. Sukeik M, Alshryda S, Haddad FS, Mason JM: Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br. 2011; 93(1): 39-46.

  50. Zhang H, Chen J, Chen F, Que W: The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012; 20(9): 1742-1752.

  51. Tan J, Chen H, Liu Q, Chen C, Huang W: A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res. 2013; 184(2): 880-7.

  52. Zhou XD, Tao LJ, Li J, Wu LD: Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg. 2013; 133(7): 1017-1027.

  53. Zufferey P, Merquiol F, Laporte S, et al: Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006; 105(5): 1034-1046.

  54. Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B: The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg. 2004; 99(6): 1679-1683, table of contents.

  55. Wong J, Abrishami A, El Beheiry H, et al: Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am. 2010; 92(15): 2503-2513.

  56. Zohar E, Fredman B, Ellis M, Luban I, Stern A, Jedeikin R: A comparative study of the postoperative allogeneic blood-sparing effect of tranexamic acid versus acute normovolemic hemodilution after total knee replacement. Anesth Analg. 1999; 89(6): 1382-1387.

  57. Ellis MH, Fredman B, Zohar E, Ifrach N, Jedeikin R: The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. J Clin Anesth. 2001; 13(7): 509-513.

  58. Jansen AJ, Andreica S, Claeys M, D’Haese J, Camu F, Jochmans K: Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth. 1999; 83(4): 596-601.

  59. Alvarez JC, Santiveri FX, Ramos I, Vela E, Puig L, Escolano F: Tranexamic acid reduces blood Transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion. 2008; 48(3): 519-525.

  60. Benoni G, Fredin H: Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br. 1996; 78(3): 434-440.

  61. Camarasa MA, Olle G, Serra-Prat M, et al: Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth. 2006; 96(5): 576-582.

  62. Engel JM, Hohaus T, Ruwoldt R, Menges T, Jurgensen I, Hempelmann G: Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg. 2001; 92(3): 775-780.

  63. Hiippala S, Strid L, Wennerstrand M, et al: Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth. 1995; 74(5): 534-537.

  64. Hiippala ST, Strid LJ, Wennerstrand MI, et al: Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg. 1997; 84(4): 839-844.

  65. Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE: Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br. 2007; 89(3): 306-309.

  66. Benoni G, Fredin H, Knebel R, Nilsson P: Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand. 2001; 72(5): 442-448.

  67. Benoni G, Lethagen S, Nilsson P, Fredin H: Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand. 2000; 71(3): 250-254.

  68. Claeys MA, Vermeersch N, Haentjens P: Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg. 2007; 107(4): 397-401.

  69. Ekback G, Axelsson K, Ryttberg L, et al: Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg. 2000; 91(5): 1124-1130.

  70. Garneti N, Field J: Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty. 2004; 19(4): 488-492.

  71. Husted H, Blond L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P: Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand. 2003; 74(6): 665-669.

  72. Ido K, Neo M, Asada Y, et al: Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg. 2000; 120(9): 518-520.

  73. Johansson T, Pettersson LG, Lisander B: Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthop. 2005; 76(3): 314-319.

  74. Lemay E, Guay J, Cote C, Roy A: Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth. 2004; 51(1): 31-37.

  75. Niskanen RO, Korkala OL: Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop. 2005; 76(6): 829-832.

  76. Yamasaki S, Masuhara K, Fuji T: Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop. 2004; 28(2): 69-73.

  77. Lin PC, Hsu CH, Huang CC, Chen WS, Wang JW: The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: is an additional pre-operative injection effective? J Bone Joint Surg Br. 2012; 94(7): 932-936.

  78. Aguilera X, Videla S, Almenara M, Fernandez JA, Gich I, Celaya F: Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Orthop Belg. 2012; 78(1): 68-74.

  79. Oremus K, Sostaric S, Trkulja V, Haspl M: Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion. Apr 25 2013.

  80. Diiorio TM, Burkholder JD, Good RP, Parvizi J, Sharkey PF: Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA. Clin Orthop Relat Res. 2012; 470(1): 138-143.

  81. Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA: The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop. 2007; 31(3): 309-313.

  82. Berghoff WJ, Pietrzak WS, Rhodes RD: Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006; 29(7): 590-598.

  83. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW: Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. Acta Orthop. 2011; 82(6): 660-663.

  84. Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T: Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surg (Hong Kong). 2006; 14(2): 117-121.

  85. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H: The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am. 1999; 81(11): 1580-1588.

  86. Wang GJ, Goldthwaite CA Jr, Burks S, Crawford R, Spotnitz WD: Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants. 2003; 13(5): 399-411.

  87. Wang GJ, Hungerford DS, Savory CG, et al: Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001; 83-A(10): 1503-1505.

  88. Carless PA, Henry DA, Moxey AJ, O’Connell D, Brown T, Fergusson DA: Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010(4): CD001888.

  89. Waters JH: Indications and contraindications of cell salvage. Transfusion. 2004; 44(12 Suppl): 40S-44S.

  90. Spahn DR: Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010; 113(2): 482-495.

  91. Feagan BG, Wong CJ, Kirkley A, et al: Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med. 2000; 133(11): 845-854.

  92. Delasotta LA, Rangavajjula A, Frank ML, Blair J, Orozco F, Ong A: The use of preoperative epoetin-alpha in revision hip arthroplasty. Open Orthop J. 2012; 6: 179-183.

  93. Delasotta LA, Rangavajjula AV, Frank ML, Blair JL, Orozco FR, Ong AC: The Use of Epoetin-alpha in revision knee arthroplasty. Adv Orthop. 2012; 2012: 595027.

  94. Robinson AH, Drew S, Anderson J, Bentley G, Ridgway GL: Suction tip contamination in the ultraclean-air operating theatre. Ann R Coll Surg Engl. 1993; 75(4): 254-256.

  95. Strange-Vognsen HH, Klareskov B: Bacteriologic contamination of suction tips during hip arthroplasty. Acta Orthop Scand. 1988; 59(4): 410-411.




2020     |     www.medigraphic.com